A first in man study to evaluate the safety, pharmacokinetics and pharmacodynamics of RP7214, a dihydroorotate dehydrogenase inhibitor in healthy subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A first in man study to evaluate the safety, pharmacokinetics and pharmacodynamics of RP7214, a dihydroorotate dehydrogenase inhibitor in healthy subjects

Published:2022-11 Issue:3 Volume:89 Page:1127-1138
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Nair Ajit¹^ORCID,Barde Prajak J.¹,Routhu Kasi V.¹,Viswanadha Srikant¹,Veeraraghavan Sridhar¹,Pak Samuel²,Peterson Jeffrey A.³,Vakkalanka Swaroop¹

Affiliation:

1. Rhizen Pharmaceuticals AG Basel Switzerland

2. Novum Pharmaceutical Research Services Las Vegas Nevada USA

3. Novum Pharmaceutical Research Services West Fargo North Dakota USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15562

Reference25 articles.

1. Dihydroorotate dehydrogenase: A drug target for the development of antimalarials

2. Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery a series of novel inhibitors of human dihydroorotate dehydrogenase: Biological activity evaluation and molecular docking;Chemical Biology & Drug Design;2023-11-05

2. Development of a Potent Nurr1 Agonist Tool for In Vivo Applications;Journal of Medicinal Chemistry;2023-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP